551 Pegasus Skin, a study of SAR444245 (THOR-707, a pegylated recombinant non-alpha IL2) with cemiplimab for the treatment of participants with advanced unresectable or metastatic skin cancers
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2021-11-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| _version_ | 1819009420661620736 |
|---|---|
| author | Paolo A Ascierto Giovanni Abbadessa Brigitte Demers PARK John Adyb Baakili Rao Saleem Alice Gosselin |
| author_facet | Paolo A Ascierto Giovanni Abbadessa Brigitte Demers PARK John Adyb Baakili Rao Saleem Alice Gosselin |
| author_sort | Paolo A Ascierto |
| collection | DOAJ |
| first_indexed | 2024-12-21T00:56:05Z |
| format | Article |
| id | doaj.art-35b3bb6d7ccb407493633e280e9d64ff |
| institution | Directory Open Access Journal |
| issn | 2051-1426 |
| language | English |
| last_indexed | 2024-12-21T00:56:05Z |
| publishDate | 2021-11-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | Journal for ImmunoTherapy of Cancer |
| spelling | doaj.art-35b3bb6d7ccb407493633e280e9d64ff2022-12-21T19:21:18ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262021-11-019Suppl 210.1136/jitc-2021-SITC2021.551551 Pegasus Skin, a study of SAR444245 (THOR-707, a pegylated recombinant non-alpha IL2) with cemiplimab for the treatment of participants with advanced unresectable or metastatic skin cancersPaolo A Ascierto0Giovanni Abbadessa1Brigitte Demers2PARK John3Adyb Baakili4Rao Saleem5Alice Gosselin6Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Campania, Italy1Sanofi, Cambridge, USA17Sanofi, Cambridge, MA, USA1Macquarie University, Macquarie, Australia2Sanofi-Aventis, Vitry-sur-Seine, France3Sanofi, Cambridge, MA, USA2Sanofi-Aventis, Vitry-sur-Seine, France |
| spellingShingle | Paolo A Ascierto Giovanni Abbadessa Brigitte Demers PARK John Adyb Baakili Rao Saleem Alice Gosselin 551 Pegasus Skin, a study of SAR444245 (THOR-707, a pegylated recombinant non-alpha IL2) with cemiplimab for the treatment of participants with advanced unresectable or metastatic skin cancers Journal for ImmunoTherapy of Cancer |
| title | 551 Pegasus Skin, a study of SAR444245 (THOR-707, a pegylated recombinant non-alpha IL2) with cemiplimab for the treatment of participants with advanced unresectable or metastatic skin cancers |
| title_full | 551 Pegasus Skin, a study of SAR444245 (THOR-707, a pegylated recombinant non-alpha IL2) with cemiplimab for the treatment of participants with advanced unresectable or metastatic skin cancers |
| title_fullStr | 551 Pegasus Skin, a study of SAR444245 (THOR-707, a pegylated recombinant non-alpha IL2) with cemiplimab for the treatment of participants with advanced unresectable or metastatic skin cancers |
| title_full_unstemmed | 551 Pegasus Skin, a study of SAR444245 (THOR-707, a pegylated recombinant non-alpha IL2) with cemiplimab for the treatment of participants with advanced unresectable or metastatic skin cancers |
| title_short | 551 Pegasus Skin, a study of SAR444245 (THOR-707, a pegylated recombinant non-alpha IL2) with cemiplimab for the treatment of participants with advanced unresectable or metastatic skin cancers |
| title_sort | 551 pegasus skin a study of sar444245 thor 707 a pegylated recombinant non alpha il2 with cemiplimab for the treatment of participants with advanced unresectable or metastatic skin cancers |
| work_keys_str_mv | AT paoloaascierto 551pegasusskinastudyofsar444245thor707apegylatedrecombinantnonalphail2withcemiplimabforthetreatmentofparticipantswithadvancedunresectableormetastaticskincancers AT giovanniabbadessa 551pegasusskinastudyofsar444245thor707apegylatedrecombinantnonalphail2withcemiplimabforthetreatmentofparticipantswithadvancedunresectableormetastaticskincancers AT brigittedemers 551pegasusskinastudyofsar444245thor707apegylatedrecombinantnonalphail2withcemiplimabforthetreatmentofparticipantswithadvancedunresectableormetastaticskincancers AT parkjohn 551pegasusskinastudyofsar444245thor707apegylatedrecombinantnonalphail2withcemiplimabforthetreatmentofparticipantswithadvancedunresectableormetastaticskincancers AT adybbaakili 551pegasusskinastudyofsar444245thor707apegylatedrecombinantnonalphail2withcemiplimabforthetreatmentofparticipantswithadvancedunresectableormetastaticskincancers AT raosaleem 551pegasusskinastudyofsar444245thor707apegylatedrecombinantnonalphail2withcemiplimabforthetreatmentofparticipantswithadvancedunresectableormetastaticskincancers AT alicegosselin 551pegasusskinastudyofsar444245thor707apegylatedrecombinantnonalphail2withcemiplimabforthetreatmentofparticipantswithadvancedunresectableormetastaticskincancers |